SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029555
Filing Date
2018-11-14
Accepted
2018-11-14 16:02:33
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-10q_20180930.htm 10-Q 2825341
2 EX-3.1 stro-ex31_551.htm EX-3.1 43271
3 EX-3.2 stro-ex32_563.htm EX-3.2 256166
4 EX-31.1 stro-ex311_871.htm EX-31.1 17555
5 EX-31.2 stro-ex312_872.htm EX-31.2 17400
6 EX-32.1 stro-ex321_869.htm EX-32.1 7506
7 EX-32.2 stro-ex322_870.htm EX-32.2 7536
  Complete submission text file 0001564590-18-029555.txt   11043400

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT stro-20180930.xml EX-101.INS 2599534
9 XBRL TAXONOMY EXTENSION SCHEMA stro-20180930.xsd EX-101.SCH 69837
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stro-20180930_cal.xml EX-101.CAL 43484
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stro-20180930_def.xml EX-101.DEF 331303
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20180930_lab.xml EX-101.LAB 514943
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20180930_pre.xml EX-101.PRE 448769
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 181183501
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences